Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life

OBJECTIVE—To evaluate the cost-effectiveness of interferon beta-1b (IFβ-1b) for relapsing-remitting multiple sclerosis (RRMS).
METHODS—Construction of a cost-effectiveness model using published data on IFβ-1b effectiveness and the natural history of RRMS, and new data on costs and quality of life (Q...

Full description

Saved in:
Bibliographic Details
Main Authors: Parkin, D., Jacoby, A., McNamee, P., Miller, P., Thomas, S., Bates, D.
Format: Artigo
Language:Inglês
Published: BMJ Group 2000
Subjects:
Papers
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736797/
https://ncbi.nlm.nih.gov/pubmed/10644777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.68.2.144
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items